Utilizing Aspirin to Lower Stroke Rates in Cerebral Amyloid Antipathy: Sheheryar Jamali, MD
The neurologist from Mayo Clinic discussed his abstract at AAN 2021 comparing stroke rates in patients with cerebral amyloid antipathy given treatment with aspirin.
Expanded Research on Targeting Mechanisms of Parkinson Disease: Rodolfo Savica, MD, PhD
The consultant in the Department of Neurology at Mayo Clinic discussed the mechanisms of action researchers should key in on for patients with Parkinson disease.
Growth of Parkinson Disease Knowledge: Rodolfo Savica, MD, PhD
The consultant in the Department of Neurology at Mayo Clinic discussed the advancements of Parkinson disease knowledge and treatment over the past 2 decades.
The Numerous Needs for Parkinson Disease: Rodolfo Savica, MD, PhD
The consultant in the Department of Neurology at Mayo Clinic discussed the mounting number of unmet needs for patients with Parkinson disease.
NeuroVoices: Rodolfo Savica, MD, PhD, on Parkinson Disease Awareness Month
The consultant in the department of neurology at Mayo Clinic detailed a number of topics surrounding Parkinson Disease Awareness Month, including the progress made in the last 2 decades.
Migraine-Related Sensory Hypersensitivity Symptoms Associated With History of Abuse
Patients with a history of abuse reported a higher average or median questionnaire scores that focused on anxiety, depression, photophobia, hyperacusis, ictal allodynia, and interictal allodynia.
Importance of Parkinson Disease Awareness Month: Rodolfo Savica, MD, PhD
The consultant in the department of neurology at Mayo Clinic discussed Parkinson Disease Awareness Month and the benefits behind social initiatives that raise awareness.
Next Steps in Improving Autoimmune Encephalitis Care
The assistant professor of neurology at Mayo Clinic detailed the areas of autoimmune encephalitis research that need more attention, as well as the diagnostic potential of autoantibody assays.
Medication Overuse Headache in Chronic Migraine Linked to High Burden
In a study of more than 600 patients, single medication classes were overused by 70% of patients, and less than half of the cohort was taking a preventive treatment.
Understanding the Momentum in the Autoimmune Encephalitis Research Community
The assistant professor of neurology at Mayo Clinic discussed his presented talk at ACTRIMS Forum 2021 on autoimmune encephalitis.
Expanding Research in Autoimmune Encephalitis: Divyanshu Dubey, MBBS
The assistant professor of neurology at Mayo Clinic provided his thoughts on the next steps in understanding autoimmune encephalitis and the direction that research must pivot to.
Prevalence of Autoimmune Encephalitis: Divyanshu Dubey, MBBS
The assistant professor of neurology at Mayo Clinic detailed his presentation at ACTRIMS 2021 Forum on the rising prevalence of autoimmune encephalitis.
Low Amyloid-β Deposition, Dopaminergic Activity Characterize MCI With Lewy Body Dementia
Researchers found amyloid-β positron emission tomography imaging and dopamine transporter imaging to be useful in characterizing phenotypes of the neurodegenerative conditions.
Alzheimer Disease Book Offers Updated Resource for Patients, Care Partners
Mayo Clinic's section edition book helps patients with Alzheimer disease and their caregivers answer questions as a guidance method.
Relying on Non-Medication for Drug-Resistant Epilepsy
A Q&A from the Mayo Clinic dives into the methods to treat drug-resistant epilepsy that aren't medication based.
Mayo Clinic Continues Efforts to Diagnose Rare Neurodegenerative Disorder
Researchers from the Mayo Clinic found a molecular target that can help assess potential treatments for spinocerebellar ataxia type 3, a disease which currently has no cure.
Protein in Blood May Predict Prognosis, Recovery From Stroke
The amount of neurofilament light may be indicative of neuron injury in the brain.
Earlier Menopause, Fewer Pregnancies Linked to Early Onset of Progressive MS
Results from a study showed that the higher number of pregnancies, the later the progressive multiple sclerosis onset.
Amyloid ß and Tau Pathology Linked to Dementia With Lewy Bodies Phenotype
The findings of this multicenter cohort may have implications for diagnosis, prognosis, and disease monitoring, as well as for clinical trials targeting disease-specific proteins in DLB.
Building on Advancements in Alzheimer Disease Diagnostic Methods
Jonathan Graff-Radford, MD, neurologist at Mayo Clinic, discussed how recent diagnostic advancements have propelled research efforts into uncharted territory.
Jonathan Graff-Radford, MD: Blood Tests as a Diagnostic Innovation in Alzheimer Disease
The neurologist at Mayo Clinic detailed promising diagnostic tools, including the revelation of blood tests in patients with Alzheimer disease.
Jonathan Graff-Radford, MD: Efforts to Reduce Rates of Alzheimer Disease Dementia
The neurologist at Mayo Clinic shares his thoughts on the state of Alzheimer disease awareness and what can be done to lower dementia rates.
Researchers Characterize Rare Form of Aggressive Alzheimer Disease
Researchers from Mayo Clinic reported characteristics of 55 patients with a newly defined form of Alzheimer disease with unusual or atypical symptoms.
Migraine History Linked to Recurrent Transient Global Amnesia
Findings suggest that compared with isolated cases, both earlier age at initial episode and a higher prevalence of personal and family history of migraine are linked to TGA recurrence.
Percept PC Deep Brain Stimulation System Gets Go-Ahead
The Medtronic device is the only DBS system that is eligible to be used for both 3T and 1.5T full-body MRI scans, with the first implant procedure scheduled at Mayo Clinic.
Adjusting Epilepsy Care During the COVID-19 Pandemic
The director of pediatric epilepsy and professor of neurology at Mayo Clinic detailed how care for patients with epilepsy has changed during the COVID-19 pandemic.
Elaine Wirrell, MD: Adjusting Epilepsy Care For Telemedicine
The director of pediatric epilepsy and professor of neurology at Mayo Clinic details the rampant acceleration of telemedicine and how her practice is adjusting to the COVID-19 pandemic.
The Evolving Landscape of Migraine Treatment
The assistant professor of Neurology, Concussion and Headache Medicine divisions, Mayo Clinic, Scottsdale, Arizona discussed the evolving migraine treatment landscape and how they have been incorporated into her practice.
Tips to Reduce Migraines Related to COVID-19 Stress
Mayo Clinic has provided advice to lower stress and anxiety amidst the COVID-19 pandemic.
Gene Variants May Increase Susceptibility to Accumulate Alzheimer's Protein Tau
A Mayo Clinic Study revelead an association between inherited DNA variants and the development of tau deposits in older adults.